Conteúdo sindicalizado The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Atualizado: 1 hora 26 segundos atrás

Cook Expands Line of Endoscopic Ultrasound Needles with Addition of Smallest Gage on the Market Designed for Histological and Cytological Samples

seg, 05/21/2012 - 15:42
SAN DIEGO--(Healthcare Sales & Marketing Network)--Cook Medical has added a 25 gage needle to its EchoTip® ProCore™ line of fine needle biopsy (FNB) histology needles, which are designed for use in a procedure known as endoscopic ultrasound, or EUS. Th...
Devices, Oncology
Cook Medical, EchoTip, ProCore, fine needle biopsy

Cook Medical Launches First Drug-Eluting Stent in Australia to Treat Peripheral Arterial Disease (PAD)

seg, 05/21/2012 - 13:22
Latest addition to Cook Medical’s Leg Therapies product line, Zilver® PTX® Drug-Eluting Peripheral Stent, is designed to treat PAD in the superficial femoral artery (SFA) BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--Cook Medical...
Devices, Interventional, Regulatory
Cook Medical, Zilver PTX, Peripheral Stent, drug eluting stent

Opexa Therapeutics Announces Tcelna(TM) as New Brand Name for MS Therapy

seg, 05/21/2012 - 13:17
THE WOODLANDS, Texas--(Healthcare Sales & Marketing Network)--Opexa Therapeutics, Inc. (NASDAQ:OPXA ), a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company is rebranding its leading MS ther...
Biopharmaceuticals, Neurology
Opexa Therapeutics, multiple sclerosis, Tovaxin, Tcelna

W. L. Gore and Associates, Inc. (Gore) Announces Extension of Distribution Agreement with ConMed Corporation (ConMed) for the GORE(R) VIABIL(R) Biliary Endoprosthesis

seg, 05/21/2012 - 13:11
FLAGSTAFF, Ariz.--(Healthcare Sales & Marketing Network)--W. L. Gore & Associates, Inc. (Gore) today announced that it has extended its distribution agreement in the US and Canada with ConMed Endoscopic Technologies for the distribution and marketing of it...
Devices, Interventional, Gastroenterology, Distribution
W. L. Gore, ConMed, Biliary Endoprosthesis, biliary stricture

GenVec Appoints Cynthia Collins as President and CEO

seg, 05/21/2012 - 13:07
GAITHERSBURG, Md., May 21, 2012 (HSMN NewsFeed) -- GenVec, Inc. (GNVC) today announced that effective May 23, 2012 Cynthia Collins has been appointed as President and Chief Executive Officer. In addition, Ms. Collins is expected to be appointed to the Bo...
Biopharmaceuticals, Personnel
GenVec

Apollo Endosurgery Names Former Covidien Chairman and CEO Richard J. Meelia to Board of Directors

seg, 05/21/2012 - 13:05
AUSTIN, TX--(Healthcare Sales & Marketing Network)- Apollo Endosurgery, Inc., a company focused on the development of devices that advance therapeutic endoscopy to enable an entirely new generation of endoscopic surgical procedures, today announced that Ri...
Devices, Personnel
Apollo Endosurgery

Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.

seg, 05/21/2012 - 12:58
MALVERN, Pa. and PHILADELPHIA, May 21, 2012 (HSMN NewsFeed) -- Auxilium Pharmaceuticals, Inc. (AUXL) and GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline plc (GSK.L), announced today that they have entered into an agreement for the co-promotio...
Biopharmaceuticals, Urology
Auxilium Pharmaceuticals, GlaxoSmithKline, Testim, testosterone gel

PneumRx, Inc. Acquires Key Assets From Broncus

seg, 05/21/2012 - 12:53
Acquisition bolsters PneumRx's position as a leader in interventional pulmonology MOUNTAIN VIEW, Calif., May 21, 2012 (HSMN NewsFeed) -- PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to bringing innovation and improvements to the...
Devices, Acquisitions
PneumRx, Broncus Technologies

AngioDynamics Appoints Experienced Industry Executive as Chief Technology Officer

seg, 05/21/2012 - 12:49
ALBANY, N.Y., May 21, 2012 --(HSMN NewsFeed) -- AngioDynamics (Nasdaq:ANGO ), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Ge...
Devices, Personnel
AngioDynamics

ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea

sex, 05/18/2012 - 13:11
Winx System Allows Users to Breathe Naturally Without a Mask Clinical Data From ATLAST Study to Be Presented at 2012 American Thoracic Society Conference REDWOOD CITY, CA--(Healthcare Sales & Marketing Network)- ApniCure, a medical device company foc...
Devices, FDA
Apnicure, obstructive sleep apnea, Winx, Sleep Therapy, sleep apnea

Achillion Announces Executive Promotion

sex, 05/18/2012 - 13:01
NEW HAVEN, Conn., May 18, 2012 --(HSMN NewsFeed) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN ), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced the promotion of Gauta...
Biopharmaceuticals, Personnel
Achillion Pharmaceuticals

PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

sex, 05/18/2012 - 12:56
Two-year Clinical Data Demonstrate Low Adverse Event Rates, Including No Myocardial Infarction or Stent Thrombosis, for the Boston Scientific 2.25 mm PROMUS Element Platinum Chromium Stent NATICK, Mass., May 18, 2012 (HSMN NewsFeed) -- Boston Scientif...
Devices, Interventional Cardiology
Boston Scientific, PROMUS Element, Everolimus, drug eluting stent

CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure

sex, 05/18/2012 - 12:52
Results Presented at EuroPCR Demonstrate Meaningful and Sustained Improvement in Clinical Outcomes, Suggesting Breakthrough Treatment for Heart Failure Patients PARIS & MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--CardioKinetix Inc., a me...
Devices, Interventional Cardiology
CardioKinetix, Parachute, Ventricular Partitioning Device, heart failure

First Published Study on Masimo Acoustic Respiration Rate Demonstrates Significantly Higher Patient Tolerance and Similar Accuracy Compared to Capnometry in Post-Surgical Patients

qui, 05/17/2012 - 17:48
IRVINE, Calif., May 17, 2012 (HSMN NewsFeed) -- Masimo (MASI) announced today a new study published in the May 2012 edition of the British Journal of Anaesthesia demonstrates that Masimo's acoustic respiration rate (RRa™) from rainbow® Acoustic Monit...
Devices, Monitoring, Surgery
Masimo, acoustic respiration rate, Acoustic Monitoring, respiratory depression

Minimus Spine(TM) Receives Notice of Allowance for Pre-Sterilized Vial to Create Ozone for Medical Application

qui, 05/17/2012 - 17:45
May 17, 2012 -- (Healthcare Sales & Marketing Network) -- Minimus Spine, Inc. (www.minimusspine.com) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (Application 11/527,414), adding a third patent to its...
Devices, Orthopaedic, Neurosurgery
Minimus Spine, TrioJection, ozone, disc herniation

Northwest Bio Provides Update On DCVax(R)-L Brain Cancer Trial

qui, 05/17/2012 - 15:25
Amendment Accepted By FDA, Enhancing and Upgrading the Trial 41 US Clinical Trial Sites Now In Operation BETHESDA, Md., May 17, 2012 (HSMN NewsFeed) -- Northwest Biotherapeutics (NWBO.OB) (NW Bio) announced today that it now has 41 clinical trial s...
Biopharmaceuticals, Oncology, FDA
Northwest Biotherapeutics, DCVax, Glioblastoma

Accuray Appoints Richard Pettingill, LFACHE to Board of Directors

qui, 05/17/2012 - 15:22
SUNNYVALE, Calif., May 17, 2012 (HSMN NewsFeed) -- Accuray Incorporated (ARAY), the premier radiation oncology company, announced today the appointment of Richard Pettingill, LFACHE as a member of the company's Board of Directors effective May 11, 2012. ...
Devices, Oncology, Personnel
Accuray, CyberKnife, TomoTherapy, radiotherapy

Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses

qui, 05/17/2012 - 15:19
Data from REMEDEE Study Presented at EuroPCR 2012 PARIS, May 17, 2012 (HSMN NewsFeed) -- OrbusNeich today announced that two subgroup analyses from the REMEDEE trial assessing vascular healing of the company's Combo Dual Therapy Stent versus the TAXUS...
Devices, Interventional Cardiology
OrbusNeich, Combo Dual Therapy Stent, drug eluting stent

Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer

qui, 05/17/2012 - 15:15
SAN FRANCISCO, May 17, 2012 (HSMN NewsFeed) -- Varian Medical Systems (VAR) will showcase radiosurgery technologies for treating early-stage inoperable lung cancer and other conditions non-invasively at the 2012 International Conference of the American T...
Devices, Oncology
Varian Medical Systems, RapidArc, Radiosurgery, TrueBeam, radiotherapy

Covidien Introduces HALO90 ULTRA Ablation Catheter for Treatment of Barrett’s Esophagus

qui, 05/17/2012 - 12:23
New, longer radiofrequency ablation catheter treats larger areas of disease SUNNYVALE, Calif.--(Healthcare Sales & Marketing Network)--Covidien (NYSE: COV ), a leading global provider of healthcare products, today announced the launch of the HALO90 ULTR...
Devices, Gastroenterology
Covidien, HALO90 ULTRA, Ablation Catheter, Barrett’s esophagus, endoscopy

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong